<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Berkeley_Wetlab_Passenger_TypeIII_Needle_scFv"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu"><UL><LI class="selected"><A href="/Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Berkeley Wetlab/Passenger: TypeIII Needle scFv</H1><DIV id="bodyContent"><H3 id="siteSub">From 2009.igem.org</H3><DIV id="contentSub">(Redirected from <A href="/wiki/index.php?title=Team:Berkeley_Wetlab/Passenger:TypeIII_Needle_scFv&amp;redirect=no" title="Team:Berkeley Wetlab/Passenger:TypeIII Needle scFv">Team:Berkeley Wetlab/Passenger:TypeIII Needle scFv</A>)</DIV></DIV><H2><SPAN class="mw-headline" id="TypeIII_Needle_scFv">TypeIII Needle scFv</SPAN></H2><P>The TypeIII secretion system (TTSS) is present in many pathogenic bacteria such as E. Coli O157:H7 and is a mechanism of their virulence. Specifically, EspA, a subunit of the TypeIII secretion complex, is a virulence factor expressed by both Enteropathogenic and Enterohaemorrhagic (EHEC)bacteria. It has a filament structure that aids in delivery of effector proteins to the host cell. Conditions such as haemorrhagic colitis are caused by EHEC. The surface display of an scFv (single-chain variable fragment) that can bind to espA can disrupt the function of the TTSS, which may have probiotic as well as pathogen detection applications.
</P><H2><SPAN class="mw-headline" id="Functional_Assay:_Dot_Blot">Functional Assay: Dot Blot</SPAN></H2><P><B>This assay measures the success of E. coli surface display of typeIII needle scFv and its ability to bind specifically to espA protein, a subunit of the typeIII needle complex in EHEC.</B></P><P><B>basic theory behind experiment</B> The incubation of cells expressing the anti-espA scFv with espA protein allows for specific binding. The washes following incubation separates the bound and unbound espA proteins, such that when the cells are lysed, only the bound espA protein is released into solution and subsequently blotted onto the nitrocellulose. An anti-his antibody conjugated to HRP is used to probe the blot for the his-tagged espA. Signals are read via chemiluminescence. 
</P><P><B>constructs:</B>
Needle scFv (14)
Gliadin neg control (2)
No pass neg control (14)
1363 negative control (1)</P><P><I>All experiments are done in triplicate</I></P><H4><SPAN class="mw-headline" id="cell_growth_and_induction">cell growth and induction</SPAN></H4><OL><LI>inoculate cells from stock into LB with appropriate antibiotics and grow to saturation overnight (12+ hours)
</LI><LI>dilute culture 1:100 into media with arabinose and induce for 5-12hours 
</LI><LI>pipet 100ul of cells to Costar V-bottom polystyrene plate and take OD
</LI><LI>pellet cells and flick out media
</LI></OL><H4><SPAN class="mw-headline" id="incubation_with_espA_protein">incubation with espA protein</SPAN></H4><OL><LI>add 5ul of espA protein to 95ul of PBS buffer and resuspend cells in solution
</LI><LI>incubate for 1.5 hours
</LI><LI>wash 3X with PBS buffer on plate washer
</LI><LI>take OD on 3rd wash
</LI><LI>after last wash, pellet cells, and resuspend in 50ul lysis buffer 
</LI><LI>heat for 15-20 minutes to lyse all cells
</LI></OL><H4><SPAN class="mw-headline" id="dot_blot_and_visualization">dot blot and visualization</SPAN></H4><OL><LI>pipet 5ul of cell lysate onto nitrocellulose paper and allow to dry completely</LI><LI>wet nitrocellulose with 10ml of 1X TBST for 5minutes</LI><LI>block with 2% BSA (.2g BSA in 10ml 1X TBST)for 1 hour</LI><LI>wash 3X with TBST - 5minutes/wash
</LI><LI>add 4ml of 1:500 Anti-His HRP: TBST, wait 30minutes 
</LI><LI>wash 3X with TBST - 5minutes/wash
</LI><LI>leave the last wash on for developing
</LI><LI>add 3mls of chemiluminescent reagents to the nitrocellulose paper and take pictures
</LI></OL><P><A href="https://2009.igem.org/Recipes" class="external text" rel="nofollow">TBST recipe</A></P><H2><SPAN class="mw-headline" id="Results">Results</SPAN></H2><H4><SPAN class="mw-headline" id="Displayers_.2B_TypeIII_Needle_scFv">Displayers + TypeIII Needle scFv</SPAN></H4><P><FONT color="turquoise">lysis buffer only negative</FONT><FONT color="green">gliadin scFv negative</FONT><FONT color="blue">No display (1363) negative</FONT>
Most of the constructs have signals larger than the negative control, but two of them gave higher signals than the rest: hia and upaG_short.</P><P>These dot blots have not been normalized to protein concentration. However, this does not make a significant difference in the results since the starting ODs (indicating growth) of the bacteria for the constructs and negative controls do not significantly differ.</P><P>
The negative controls did not have significant signal.
</P><P>
There is some detectable background as denoted by the slight signals in the column with just lysis buffer.
Several of the Needle scFv constructs did have positive signals higher than that of the negative controls. (yuaQ and upaG_short) </P><H4><SPAN class="mw-headline" id="Displayers_Only_.28negative.29">Displayers Only (negative)</SPAN></H4><P>
No detectable signal is present in the set of experiments run with only displays expressed from the cells. 
</P><P>There were three constructs that showed higher signals consistently in all three sets of experiments. They are AIDA, espP, and cpg_L2.
</P><H4><SPAN class="mw-headline" id="Quantitaive_Image_J_Analysis_of_Dot_Blots">Quantitaive Image J Analysis of Dot Blots</SPAN></H4><P>
This data represents the averaged fold increase of three sets of data normalized to the negative control. The data indicates preliminarily the functional display of scFv with displayers Hia, upaG_short, yuaQ, CPG_L2, and espP(beta).
</P><H3><SPAN class="mw-headline" id="References">References</SPAN></H3><P>La Ragione, R et al. Recombinant anti-EspA antibodies block Escherichia coli O157:H7-induced attaching and effacing lesions in vitro. Microbes and Infection. September 2005; 8: 426–433. Available Online: <A href="http://www.sciencedirect.com/science?_ob=MImg&amp;_imagekey=B6VPN-4H4T215-1-7&amp;_cdi=6211&amp;_user=4420&amp;_orig=search&amp;_coverDate=02%2F28%2F2006&amp;_sk=999919997&amp;view=c&amp;wchp=dGLbVtz-zSkzS&amp;md5=f35699db5dcd202f4cd1c1d8739d89b0&amp;ie=/sdarticle.pdf" class="external free" rel="nofollow">http://www.sciencedirect.com/science?_ob=MImg&amp;_imagekey=B6VPN-4H4T215-1-7&amp;_cdi=6211&amp;_user=4420&amp;_orig=search&amp;_coverDate=02%2F28%2F2006&amp;_sk=999919997&amp;view=c&amp;wchp=dGLbVtz-zSkzS&amp;md5=f35699db5dcd202f4cd1c1d8739d89b0&amp;ie=/sdarticle.pdf</A> (Accessed: 20 October 2009).
</P><DIV class="printfooter">
Retrieved from &quot;<A href="http://2009.igem.org/Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv">http://2009.igem.org/Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv</A>&quot;</DIV></DIV></DIV><DIV id="footer-box"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Berkeley_Wetlab/Passenger:_TypeIII_Needle_scFv&amp;oldid=150147" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2009.igem.org:Privacy_policy" title="2009.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2009.igem.org:General_disclaimer" title="2009.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></BODY></HTML>